ConductScience.org, home
Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease
API referenceFor AI assistants

Trial · NCT01387178

Results by group32

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 32

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Post-index Period COPD-related, Unadjusted CostsFluticasone Propionate/Salmeterol 250 Micrograms (µg)/50 µgInpatient services688Standard Deviation 4998United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsTiotropium Bromide 18 µgInpatient services867Standard Deviation 6887United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsFluticasone Propionate/Salmeterol 250 Micrograms (µg)/50 µgEmergency department visits55Standard Deviation 415United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsTiotropium Bromide 18 µgEmergency department visits52Standard Deviation 363United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsFluticasone Propionate/Salmeterol 250 Micrograms (µg)/50 µgInpatient and emergency department visits743Standard Deviation 5090United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsTiotropium Bromide 18 µgInpatient and emergency department visits919Standard Deviation 6977United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsFluticasone Propionate/Salmeterol 250 Micrograms (µg)/50 µgOffice visits231Standard Deviation 388United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsTiotropium Bromide 18 µgOffice visits293Standard Deviation 559United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsFluticasone Propionate/Salmeterol 250 Micrograms (µg)/50 µgOther outpatient/ancillary services734Standard Deviation 2504United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsTiotropium Bromide 18 µgOther outpatient/ancillary services879Standard Deviation 3050United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsFluticasone Propionate/Salmeterol 250 Micrograms (µg)/50 µgTotal medical costs1709Standard Deviation 6322United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsTiotropium Bromide 18 µgTotal medical costs2091Standard Deviation 8302United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsFluticasone Propionate/Salmeterol 250 Micrograms (µg)/50 µgTotal pharmacy costs1291Standard Deviation 1791United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsTiotropium Bromide 18 µgTotal pharmacy costs1209Standard Deviation 1378United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsFluticasone Propionate/Salmeterol 250 Micrograms (µg)/50 µgTotal healthcare utilization3000Standard Deviation 6805United States (US) dollars
Post-index Period COPD-related, Unadjusted CostsTiotropium Bromide 18 µgTotal healthcare utilization3299Standard Deviation 8536United States (US) dollars
Mean Number of COPD ExacerbationsFluticasone Propionate/Salmeterol 250 Micrograms (µg)/50 µgModerate Exacerbation0.35Standard Deviation 0.77number of exacerbations
Mean Number of COPD ExacerbationsTiotropium Bromide 18 µgModerate Exacerbation0.29Standard Deviation 0.71number of exacerbations
Mean Number of COPD ExacerbationsFluticasone Propionate/Salmeterol 250 Micrograms (µg)/50 µgSevere Exacerbation0.05Standard Deviation 0.29number of exacerbations
Mean Number of COPD ExacerbationsTiotropium Bromide 18 µgSevere Exacerbation0.05Standard Deviation 0.32number of exacerbations

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01387178/results

API referenceFor AI assistants